Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Vennegoor
PML-IRIS During Fingolimod Diagnosed After Natalizumab Discontinuation
Case Reports in Neurological Medicine
Related publications
Predictors for Multiple Sclerosis Relapses After Switching From Natalizumab to Fingolimod
Multiple Sclerosis
Neurology
Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurology
Neurology
Fingolimod-Associated PML in a Patient With Prior Immunosuppression
Neurology
Neurology
Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Immunological Markers for PML Prediction in MS Patients Treated With Natalizumab
Frontiers in Immunology
Allergy
Immunology
Long-Term Evaluation of NEDA-3 Status in Relapsing-Remitting Multiple Sclerosis Patients After Switching From Natalizumab to Fingolimod
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities
Multiple Sclerosis International
Neurology
Incomplete Susac Syndrome Exacerbated After Natalizumab
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting
Journal of Neurology & Neurophysiology